Driving the Business of Science

De-Risking Diagnostics for Maternal Health and Beyond

In this episode of the Driving the Business of Science [https://courtsquaregroup.com/driving-the-business-of-science-podcast/] podcast, host Keith Parent [https://courtsquaregroup.com/leadership_team/keith-parent/], CEO of Court Square Group [https://courtsquaregroup.com/], speaks with Dean Remy [https://www.linkedin.com/company/mativadx/], Co-founder & COO/ CCO of Mativa Diagnostics [https://www.mativadx.com/] about innovation in the life science industry and women’s health. Dean shares insights from his 35-year career across diagnostics, biotech, and therapeutics, with a growing focus on maternal health. Mativa is developing a diagnostic platform for pregnancy that can detect ectopic pregnancy and preeclampsia, significantly improving test sensitivity and providing more comprehensive care pathways. Their AI-enabled, app-driven platform connects women to a free maternal ecosystem that supports both mental and physical health. Dean also discusses Matiba’s planned $125 million fundraising round to develop multiple MVPs—including chips for pregnancy and risk factors, pregnancy maintenance checks, gestational diabetes, STIs, and drugs-of-abuse—alongside a first-in-class maternal biorepository. This biorepository is designed to de-risk investment by spinning out as a uniquely valuable sample and data asset, targeting over 1 million cryopreserved samples across diverse populations, age groups, sample types, and longitudinal time points during and beyond pregnancy.  Driving the Business of Science [https://courtsquaregroup.com/driving-the-business-of-science-podcast/] is the podcast for clinical operations, IT, and business managers in the pharma, biotech, and medical device world. Bringing new products to market takes more than just great science. From R&D and clinical to regulatory and approval life science leaders require fit-for-purpose technology, processes, and partners at step. In the Driving the Business of Science podcast leaders from across the life science industry share real-world experiences and practical insights that will impact your business. Join host Keith Parent [https://courtsquaregroup.com/leadership_team/keith-parent/], serial life science CEO, as business leaders share experiences and insights on emerging challenges in the life science market.

Future-Proofing Platforms in FDA-Grade Analytics

In this episode of the Driving the Business of Science [https://courtsquaregroup.com/driving-the-business-of-science-podcast/] podcast, host Keith Parent [https://courtsquaregroup.com/leadership_team/keith-parent/], CEO of Court Square Group [https://courtsquaregroup.com/], speaks with Kristin Seastrand [https://www.linkedin.com/in/kristinseastrand/] of Siemens Digital Industries Software [https://www.siemens.com/en-us/] about how life sciences organizations are modernizing their SAS environments, embracing the agentic enterprise, and preparing for the next wave of digital transformation. Kristin shares insights from over 25 years in life sciences, IoT, and platform modernization, explaining how Siemens’ SAS Language Compiler (SLC) and AI are helping pharma, biotech, and CROs migrate legacy analytics to more flexible, future-proof infrastructures. They discuss how SLC enables companies to reuse existing SAS code, reduce costs, and integrate seamlessly with R, Python, and modern statistical computing environments while maintaining regulatory compliance for FDA submissions. Whether you’re leading clinical operations, biometrics, or data platforms, this episode offers a practical look at how to evolve your analytics stack while keeping auditors, regulators, and your teams aligned.  Driving the Business of Science [https://courtsquaregroup.com/driving-the-business-of-science-podcast/] is the podcast for clinical operations, IT, and business managers in the pharma, biotech, and medical device world. Bringing new products to market takes more than just great science. From R&D and clinical to regulatory and approval life science leaders require fit-for-purpose technology, processes, and partners at step. In the Driving the Business of Science podcast leaders from across the life science industry share real-world experiences and practical insights that will impact your business. Join host Keith Parent [https://courtsquaregroup.com/leadership_team/keith-parent/], serial life science CEO, as business leaders share experiences and insights on emerging challenges in the life science market.

Solving Drug Shortages One Medicine at a Time

In this episode of the Driving the Business of Science [https://courtsquaregroup.com/driving-the-business-of-science-podcast/] podcast, host Keith Parent [https://courtsquaregroup.com/leadership_team/keith-parent/], CEO of Court Square Group [https://courtsquaregroup.com/], discusses the challenges of drug development and shortages with Sarah Norring [https://www.linkedin.com/in/sarah-a-norring-phd-100294b/], Ph.D., Co‑founder and CEO of Plenitude Pharma [https://plenitudepharma.com/] Inc. Sarah highlights the critical need to address drug shortages and discontinuations, emphasizing the importance of having multiple manufacturers for essential medicines. She shares her background in medical science and her company's focus on bringing back critical drugs, particularly in women's health and oncology. Sarah mentions the FDA's expedited review process for off-patent drugs on the FDA’s drug shortage list, and her aims to bring one to two products to market within the first three years. The conversation also touches on the challenges of fundraising in this niche pharma sector. Driving the Business of Science [https://courtsquaregroup.com/driving-the-business-of-science-podcast/] is the podcast for clinical operations, IT, and business managers in the pharma, biotech, and medical device world. Bringing new products to market takes more than just great science. From R&D and clinical to regulatory and approval life science leaders require fit-for-purpose technology, processes, and partners at step. In the Driving the Business of Science podcast leaders from across the life science industry share real-world experiences and practical insights that will impact your business. Join host Keith Parent [https://courtsquaregroup.com/leadership_team/keith-parent/], serial life science CEO, as business leaders share experiences and insights on emerging challenges in the life science market.

How Technology Partner Programs Drive CRO Competitive Advantage—and Patient Impact

In this episode of the Driving the Business of Science [https://courtsquaregroup.com/driving-the-business-of-science-podcast/] podcast, host Keith Parent [https://courtsquaregroup.com/leadership_team/keith-parent/], CEO of Court Square Group [https://courtsquaregroup.com/],  interviews Mitchell Bayer [https://www.linkedin.com/in/mitchellbayer/], Managing Principal of Arlen Consulting Group [file:///C:/Users/roy/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/AH7YB9HK/arlenconsultinggroup.com], about the evolution of the life science industry and the role of CROs. Mitch discusses his 24-year career, starting at Medidata, where he spearheaded the ASPire to Win™ CRO partner program, which grew to 16 partners by 2009. He emphasizes the importance of integrating technology with CROs to enhance competitiveness and efficiency. Mitch highlights the shift from paper-based trials to electronic data capture (EDC) and the potential of AI in streamlining clinical trials. He also discusses the importance of technology that integrates seamlessly with existing systems and reduces site burden. Driving the Business of Science [https://courtsquaregroup.com/driving-the-business-of-science-podcast/] is the podcast for clinical operations, IT, and business managers in the pharma, biotech, and medical device world. Bringing new products to market takes more than just great science. From R&D and clinical to regulatory and approval life science leaders require fit-for-purpose technology, processes, and partners at step. In the Driving the Business of Science podcast leaders from across the life science industry share real-world experiences and practical insights that will impact your business. Join host Keith Parent [https://courtsquaregroup.com/leadership_team/keith-parent/], serial life science CEO, as business leaders share experiences and insights on emerging challenges in the life science market.

Beyond the Lab: Policy, Politics, and the Future of Research

In this episode of the Driving the Business of Science [https://courtsquaregroup.com/driving-the-business-of-science-podcast/] podcast, host Keith Parent [https://courtsquaregroup.com/leadership_team/keith-parent/], CEO of Court Square Group [https://courtsquaregroup.com/],  interviews Nicholas Dirks [https://www.linkedin.com/in/nicholas-dirks-84a1ab149/], President and CEO of The New York Academy of Sciences [https://www.nyas.org/]. Nick emphasizes the importance of federal funding for basic research and the need for international collaboration while highlighting the impact of the pandemic and the current administration on scientific research, funding cuts, and the exodus of international researchers. He also explains why the Academy’s efforts to connect scientists from around the world in various fields, including AI and biomedical research, is a crucially important aspect of its overall mission to drive scientific innovation and address global challenges.  Driving the Business of Science [https://courtsquaregroup.com/driving-the-business-of-science-podcast/] is the podcast for clinical operations, IT, and business managers in the pharma, biotech, and medical device world. Bringing new products to market takes more than just great science. From R&D and clinical to regulatory and approval life science leaders require fit-for-purpose technology, processes, and partners at step. In the Driving the Business of Science podcast leaders from across the life science industry share real-world experiences and practical insights that will impact your business. Join host Keith Parent [https://courtsquaregroup.com/leadership_team/keith-parent/], serial life science CEO, as business leaders share experiences and insights on emerging challenges in the life science market.